GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $793,000 | +4.1% | 21,538 | +6.3% | 0.39% | +37.5% |
Q3 2020 | $762,000 | +169.3% | 20,257 | +236.2% | 0.28% | +988.5% |
Q4 2019 | $283,000 | +16.0% | 6,026 | +5.4% | 0.03% | +18.2% |
Q3 2019 | $244,000 | -85.0% | 5,715 | -85.8% | 0.02% | -62.7% |
Q3 2018 | $1,622,000 | -1.5% | 40,369 | -1.2% | 0.06% | 0.0% |
Q2 2018 | $1,647,000 | +366.6% | 40,870 | +370.0% | 0.06% | +353.8% |
Q3 2017 | $353,000 | -79.9% | 8,695 | -78.6% | 0.01% | -80.3% |
Q2 2017 | $1,754,000 | +19.7% | 40,674 | +17.1% | 0.07% | +17.9% |
Q1 2017 | $1,465,000 | -26.1% | 34,741 | -32.5% | 0.06% | -30.9% |
Q4 2016 | $1,982,000 | +588.2% | 51,472 | +670.5% | 0.08% | +575.0% |
Q3 2016 | $288,000 | -71.6% | 6,680 | -69.6% | 0.01% | -66.7% |
Q1 2015 | $1,015,000 | +51.7% | 21,985 | +40.4% | 0.04% | +56.5% |
Q4 2014 | $669,000 | -52.7% | 15,662 | -49.0% | 0.02% | -46.5% |
Q3 2014 | $1,413,000 | -50.9% | 30,734 | -42.9% | 0.04% | -44.2% |
Q2 2014 | $2,879,000 | +58.2% | 53,828 | +58.0% | 0.08% | +57.1% |
Q1 2014 | $1,820,000 | -66.5% | 34,058 | -66.5% | 0.05% | -69.4% |
Q4 2013 | $5,428,000 | +151.2% | 101,665 | +136.0% | 0.16% | +150.0% |
Q3 2013 | $2,161,000 | – | 43,070 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
Columbia Asset Management | 9,960 | $361 | 0.08% |
PARK CIRCLE Co | 800 | $29,000 | 0.03% |
PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
Retirement Group, LLC | 40 | $1,450 | 0.00% |
Bartlett & Co. LLC | 240 | $9 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |